Plasmacytoid dendritic cells prime IFN-γ-secreting melanoma-specific CD8 lymphocytes and are found in primary melanoma lesions

European Journal of Immunology

Volumn 33, Issue 4, 2003, Pages 1052-1062

  Salio, Mariolina ^a   Cella, Marina ^b   Vermi, William ^c   Faccheti, Fabio ^c   Palmowski, Michael J ^a   Smith, Caroline L ^a   Shepherd, Dawn ^a   Colonna, Marco ^b   Cerundolo, Vincenzo ^a  

^a JOHN RADCLIFFE HOSPITAL   (United Kingdom)

^b WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c UNIVERSITY OF BRESCIA   (Italy)

Author keywords

Melan A; Plasmacytoid dendritic cell; Priming; Tetramer; Tumor immunity

Indexed keywords

CD40 LIGAND; CD8 ANTIGEN; EPITOPE; FAS ANTIGEN; GAMMA INTERFERON; HOMING RECEPTOR; L SELECTIN; LYMPHOCYTE ANTIGEN; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 1; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 2;

CELL INFILTRATION; CELL MIGRATION; CELL SURFACE; CELLULAR DISTRIBUTION; CONTROLLED STUDY; CYTOKINE RELEASE; CYTOTOXIC T LYMPHOCYTE; DENDRITIC CELL; EFFECTOR CELL; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOMODULATION; IN VITRO STUDY; IN VIVO STUDY; LEUKOCYTE; MELANOMA; PRIMARY IMMUNE RESPONSE; PRIORITY JOURNAL; PROTEIN EXPRESSION; REVIEW; SKIN INFLAMMATION; SUPERNATANT; T LYMPHOCYTE ACTIVATION; TUMOR GROWTH;

ANTIGENS, CD95; ANTIGENS, NEOPLASM; CD8-POSITIVE T-LYMPHOCYTES; DENDRITIC CELLS; HISTOCOMPATIBILITY ANTIGENS; HUMANS; INTERFERON TYPE I; INTERFERON TYPE II; INTERLEUKIN-12; LYMPHOCYTE ACTIVATION; LYMPHOCYTES, TUMOR-INFILTRATING; MELANOMA; MEMBRANE GLYCOPROTEINS; NEOPLASM PROTEINS; TUMOR CELLS, CULTURED;

EID: 0038744443     PISSN: 00142980     EISSN: None     Source Type: Journal    
DOI: 10.1002/eji.200323676     Document Type: Review

References (52)

1. Banchereau, J. and Steinman, R., Dendritic cells and the control of immunity. Nature 1998. 392: 245-252.
2. O'Doherty, U., Peng, M., Gezelter, S., Swiggard, W., Betjes, M., Bhardwaj, N. and Steinman, R., Human blood contains two subsets of dendritic cells, one immunologically mature and the other immature. Immunology 1994. 82: 487-493.
3. Strobl, H., Scheinecker, C., Riedl, E., Csmarits, B., Bello-Fernandez, C., Pickl, W., Majdic, O. and Knapp, W., Identification of CD68+lin- peripheral blood cells with dendritic precursor characteristics. J. Immunol. 1998. 161: 740-748.
4. Grouard, G., Rissoan, M., Filgueira, L., Durand, I., Banchereau, J. and Liu, Y., The enigmatic plasmacytoid T cells develop into dendritic cells with interleukin (IL)-3 and CD40-ligand. J. Exp. Med. 1997. 185: 1101-1111.
5. Celia, M., Jarrossay, D., Facchetti, F., Alebardi, O., Nakajima, H., Lanzavecchia, A. and Colonna, M., Plasmacytoid monocytes migrate to inflamed lymph nodes and produce large amounts of type I interferon. Nat. Med. 1999. 5: 919-923.
6. Dzionek, A., Sohma, Y., Nagafune, J., Cella, M., Colonna, M., Facchetti, F., Gunther, G., Johnston, I., Lanzavecchia, A., Nagasaka, T., Okada, T., Vermi, W., Winkels, G., Yamamoto, T., Zysk, M., Yamaguchi, Y. and Schmitz, J., BDCA-2, a novel Plasmacytoid Dendritic Cell-specific type II C-type lectin, mediates antigen capture and is a potent inhibitor of interferon α/β induction. J. Exp. Med. 2001. 194: 1823-1834.
7. Facchetti, F., De Wolf-Peters, C., Marocolo, D. and De Vos, R., Plasmacytoid monocytes in granulomatous lymphadenitis and in histiocytic necrotizing lymphadenitis. Sarcoidosis 1991. 8: 170-171.
8. Perussia, B., Fanning, V. and Trinchieri, G., A leukocyte subset bearing HLA-DR antigens is responsible for in vitro alpha interferon production in response to viruses. Nat. Immun. Cell Growth Regul. 1985. 4: 120-137.
9. Fitzgerald-Bocarsly, P., Feldman, M., Mendelsohn, M., Curl, S. and Lopez, C., Human mononuclear cells which produce interferon-alpha during NK(HSV-FS) assays are HLA-DR positive cells distinct from cytolytic natural killer effectors. J. Leukoc. Biol. 1988. 43: 323-334.
10. Siegal, F., Kadowaki, N., Shodell, M., Fitzgerald-Bocarsly, P., Shah, K., Ho, S., Antonenko, S. and Liu, Y., The nature of the principal type 1 interferon-producing cells in human blood. Science 1999. 284: 1835-1837.
11. Cella, M., Facchetti, F., Lanzavecchia, A. and Colonna, M., Plasmacytoid dendritic cells activated by influenza virus and CD40L drive a potent Th1 polarization. Nat. Immunol. 2000. 1: 305-310.
12. Kadowaki, N., Antonenko, S., Lau, J. and Liu, Y., Natural interferon alpha/beta-producing cells link innate and adaptive immunity. J. Exp. Med. 2000. 192: 219-226.
13. Kawakami, Y., Eliyahu, S., Delgado, C., Robbins, P., Rivoltini, L., Topalian, S., Miki, T. and Rosenberg, S., Cloning of the gene coding for a shared human melanoma antigen recognized by autologous T cells infiltrating into tumor. Proc. Natl. Acad. Sci. USA 1994. 91: 3515-3519.
14. + T cells in a large proportion of human histocompatibility leukocyte antigen (HLA)-A2 individuals. J. Exp. Med. 1999. 190: 705-715.
15. Zippelius, A., Pittet, M. J., Batard, P., Rufer, N., de Smedt, M., Guillaume, P., Ellefsen, K., Valmori, D., Lienard, D., Plum, J., MacDonald, H. R., Speiser, D. E., Cerottini, J. C. and Romero, P., Thymic selection generates a large T cell pool recognizing a self-peptide in humans. J. Exp. Med. 2002. 195: 485-494.
16. + lymphocytes as compared with non-professional antigen presenting cells. J. Immunol. 2001. 167: 1188-1197.
17. Cella, M., Scheidegger, D., Palmer-Lehmann, K., Lane, P., Lanzavecchia, A. and Alber, G., Ligation of CD40 on dendritic cells triggers production of high levels of interleukin-12 and enhances T cell stimulatory capacity: T-T help via APC activation. J. Exp. Med. 1996. 184: 747-752.
18. Rogge, L., D'Ambrosio, D., Biffi, M., Penna, G., Minetti, L., Presky, D., Adorini, L. and Sinigaglia, F., The role of Stat4 in species-specific regulation of Th cell development by type I IFNs. J. Immunol. 1998. 161: 6567-6574,
19. Hauptmann, R. and Swetly, P., A novel class of human type I interferons. Nucleic Acids Res. 1985. 13: 4739-4349.
20. Vilcek, J., Novel interferons. Nat. Immunol. 2003. 4: 8-9.
21. Facchetti, F., De Wolf-Peeters, C., Van den Oord, J. J., De Vos, R. and Desmet, V. J., Plasmacytoid T cells: a cell population normally present in the reactive lymph node. An immunohistochemical and electronmicroscopic study. Hum. Pathol. 1988. 19: 1085-1092.
22. Vermi, W., Bonecchi, R., Facchetti, F., Bianchi, D., Sozzani, S., Festa, S., Berenzi, A., Cella, M. and Colonna, M., Recruitment of immature plasmacytoid dendritic cells (plasmacytoid monocytes) and myeloid dendritic cells in primary cutaneous melanomas. J. Pathol. 2003, in press.
23. Bullani, R. R., Wehrli, P., Viard-Leveugle, I., Rimoldi, D., Cerottini, J. C., Saurat, J. H., Tschopp, J. and French, L. E., Frequent downregulation of Fas (CD95) expression and function in melanoma. Melanoma Res. 2002. 12: 263-270.
24. Soubrane, C., Mouawad, R., Antoine, E. C., Verola, O., Gil-Delgado, M. and Khayat, D., A comparative study of Fas and Fas-ligand expression during melanoma progression. Br. J. Dermatol. 2000. 143: 307-312.
25. Marrack, P., Kappler, J. and Mitchell, T., Type I interferons keep activated T cells alive. J. Exp. Med. 1999. 189: 521-530.
26. Tough, D., Sun, S., Zhang, X. and Sprent, J., Stimulation of naive and memory T cells by cytokines. Immunol. Rev. 1999. 170: 39-47.
27. Berg, E., Yoshino, T., Rott, L., Robinson, M., Warnock, R., Kishimoto, T., Picker, L. and Butcher, E., The cutaneous lymphocyte antigen is a skin lymphocyte homing receptor for the vascular lectin endothelial cell-leukocyte adhesion molecule 1. J. Exp. Med. 1991. 174: 1461-1466.
28. Picker, L., Martin, R., Trumble, A., Newman, L., Collins, P., Bergstresser, P. and Leung, D., Differential expression of lymphocyte homing receptors by human memory/effector T cells in pulmonary versus cutaneous immune effector sites. Eur. J. Immunol. 1994. 24: 1269-1277.
29. Van Wely, C., Beverley, P., Brett, S., Britten, C. and Tite, J., Expression of L-selectin on Th1 cells is regulated by IL-12. J. Immunol. 1999. 163: 1214-1221.
30. McRae, B., Picker, L. and van Seventer, G., Human recombinant interferon-beta influences T helper subset differentiation by regulating cytokine secretion pattern and expression of homing receptors. Eur. J. Immunol. 1997. 27: 2650-2656.
31. Rogge, L., Barberis-Maino, L., Biffi, M., Passini, N., Presky, D., Gubler, U. and Sinigaglia, F., Selective expression of an interleukin-12 receptor component by human T helper 1 cells. J. Exp. Med. 1997. 185: 825-831.
32. Cella, M., Salio, M., Sakakibara, Y., Langen, H., Julkunen, I. and Lanzavecchia, A., Maturation, activation, and protection of dendritic cells induced by double-stranded RNA. J. Exp. Med. 1999. 189: 821-829.
33. Schuler, G. and Steinman, R., Dendritic cells as adjuvants for immune-mediated resistance to tumors. J. Exp. Med. 1997. 186: 1183-1187.
34. Dallal, R. and Lotze, M., The dendritic cell and human cancer vaccines. Curr. Opin. Immunol. 2000. 12: 583-588.
35. Bell, D., Chomarat, P., Broyles, D., Netto, G., Harb, G., Lebecque, S., Valladeau, J., Davoust, J., Palucka, K. and Banchereau, J., In breast carcinoma tissue, immature dendritic cells reside within the tumor, whereas mature dendritic cells are located in peritumoral areas. J. Exp. Med. 1999. 190: 1417-1426.
36. Gabrilovich, D., Chen, H., Girgis, K., Cunningham, H., Meny, G., Nadaf, S., Kavanaugh, D. and Carbone, D., Production of vascular endothelial growth factor by human tumors inhibits the functional maturation of dendritic cells. Nat. Med. 1996. 2: 1096-1103.
37. Albert, M., Pearce, S., Francisco, L., Sauter, B., Roy, P., Silverstein, R. and Bhardwaj, N., Immature dendritic cells phagocytose apoptotic cells via alphavbeta5 and CD36, and cross-present antigens to cytotoxic T lymphocytes. J. Exp. Med. 1998. 188: 1359-1368.
38. Sorg, R., Kogler, G. and Wernet, P., Identification of cord blood dendritic cells as an immature CD11c- population. Blood 1999. 93: 2302-2307.
39. Allavena, P., Sica, A., Vecchi, A., Locati, M., Sozzani, S. and Mantovani, A., The chemokine receptor switch paradigm and dendritic cell migration: its significance in tumor tissues. Immunol. Rev. 2000. 177: 141-149.
40. Mellado, M., Am, D. A., Moreno, M., Martinez-A, C. and Rodriguez-Frade, J., A potential immune escape mechanism by melanoma cells through the activation of chemokine-induced T cell death. Curr. Biol. 2001. 11: 691-696.
41. Remmel, E., Terracciano, L., Noppen, C., Zajac, P., Heberer, M., Spagnoli, G. and Padovan, E., Modulation of dendritic cell phenotype and mobility by tumor cells in vitro. Hum. Immunol. 2001. 62: 39-49.
42. Zou, W., Machelon, V., Coulomb-L'Hermin, A., Borvak, J., Nome, F., Isaeva, T., Wei, S., Krzysiek, R., Durand-Gasselin, I., Gordon, A., Pustilnik, T., Curiel, D. T., Galanaud, P., Capron, F., Emilie, D. and Curiel, T. J., Stromal-derived factor-1 in human tumors recruits and alters the function of plasmacytoid precursor dendritic cells. Nat. Med. 2001. 7: 1339-1346.
43. Penna, G., Sozzani, S. and Adorini, L., Cutting edge: selective usage of chemokine receptors by plasmacytoid dendritic cells. J. Immunol. 2001. 167: 1862-1866.
44. Kayagaki, N., Yamaguchi, N., Nakayama, M., Eto, H., Okumura, K. and Yagita, H., Type I interferons (IFNs) regulate tumor necrosis factor-related apoptosis-inducing ligand (TRAIL) expression on human T cells: A novel mechanism for the antitumor effects of type I IFNs. J. Exp. Med. 1999. 189: 1451-1460.
45. + T cells after the injection of tumor cells expressing IFN-alpha1 into syngeneic mice. Cancer Res. 1998. 58: 5795-5802.
46. Lloyd, R., Blalock, J. and Stanton, G., Cell-to-cell transfer of interferon-induced antiproliferative activity. Science 1983. 221: 953-955.
47. + T cell-mediated tumor rejection involves inhibition of angiogenesis that is dependent on IFN gamma receptor expression by nonhematopoietic cells. Immunity 2000. 12: 677-686.
48. Belardelli, F. and Ferrantini, M., Cytokines as a link between innate and adaptive antitumor immunity. Trends Immunol. 2002. 23: 201-208.
49. Traunecker, A., Oliveri, F. and Karjalainen, K., Myeloma based expression system for production of large mammalian proteins. Trends Biotechnol. 1991. 9: 109-113.
50. Lane, P., Burdet, C., McConnell, F., Lanzavecchia, A. and Padovan, E., CD40 ligand-independent B cell activation revealed by CD40 ligand-deficient T cell clones: evidence for distinct activation requirements for antibody formation and B cell proliferation. Eur. J. Immunol. 1995. 25: 1788-1793.
51. Dunbar, P. R., Smith, C., Chao, D., Sallo, M., Shepherd, D., Mirza, F., Lipp, M., Lanzavecchia, A., Sallusto, F., Evans, A., Russell-Jones, R., Harris, A. and Cerundolo, V., A shift in the phenotype of melan-A-specific CTL identifies melanoma patients with an active tumor-specific immune response. J. Immunol. 2000. 165: 6644-6652.
52. Palmowski, M. J., Choi, E. M., Hermans, I. F., Gilbert, S. C., Chen J. L. Gileadi, U., Salio, M., Van Pel, A., Man, S., Bonin, E., Liljestrom, P., Dunbar, P. R. and Cerundolo, V., Competition between CTL narrows the immune response induced by primeboost vaccination protocols. J. Immunol. 2002. 168: 4391-4398.